155 related articles for article (PubMed ID: 7813389)
1. L-acetylcarnitine treatment of mental decline in the elderly.
Salvioli G; Neri M
Drugs Exp Clin Res; 1994; 20(4):169-76. PubMed ID: 7813389
[TBL] [Abstract][Full Text] [Related]
2. [Effects of L-acetylcarnitine on mental deterioration in the aged: initial results].
Cipolli C; Chiari G
Clin Ter; 1990 Mar; 132(6 Suppl):479-510. PubMed ID: 2140973
[TBL] [Abstract][Full Text] [Related]
3. Selegiline versus L-acetylcarnitine in the treatment of Alzheimer-type dementia.
Campi N; Todeschini GP; Scarzella L
Clin Ther; 1990; 12(4):306-14. PubMed ID: 2121359
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
5. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
Passeri M; Iannuccelli M; Ciotti G; Bonati PA; Nolfe G; Cucinotta D
Int J Clin Pharmacol Res; 1988; 8(5):367-76. PubMed ID: 3229874
[TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation and mild cognitive impairment: what correlation?
Puccio D; Novo G; Baiamonte V; Nuccio A; Fazio G; Corrado E; Coppola G; Muratori I; Vernuccio L; Novo S
Minerva Cardioangiol; 2009 Apr; 57(2):143-50. PubMed ID: 19274024
[TBL] [Abstract][Full Text] [Related]
7. Emotional withdrawal, CT abnormalities and drug response in late life depression.
Altamura AC; Bassetti R; Santini A; Frisoni GB; Mundo E
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):349-54. PubMed ID: 14751432
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study.
Mossello E; Tonon E; Caleri V; Tilli S; Cantini C; Cavallini MC; Bencini F; Mecacci R; Marini M; Bardelli F; Sarcone E; Razzi E; Biagini CA; Masotti G
Arch Gerontol Geriatr Suppl; 2004; (9):297-307. PubMed ID: 15207427
[TBL] [Abstract][Full Text] [Related]
9. [An experimental, randomized, double-blind, placebo-controlled clinical trial to infestigate the effect of nicardipine on cognitive function in patients with vascular dementia. Spanish group of nicardipine study in vascular dementia].
Rev Neurol; 1999 May 1-15; 28(9):835-45. PubMed ID: 10390744
[TBL] [Abstract][Full Text] [Related]
10. Effect of acetyl-L-carnitine on geriatric patients suffering from dysthymic disorders.
Bella R; Biondi R; Raffaele R; Pennisi G
Int J Clin Pharmacol Res; 1990; 10(6):355-60. PubMed ID: 2099360
[TBL] [Abstract][Full Text] [Related]
11. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M
Arch Gerontol Geriatr; 2008; 46(2):181-90. PubMed ID: 17658628
[TBL] [Abstract][Full Text] [Related]
12. [Methodology of a clinical controlled study of L-acetylcarnitine].
Neri M; Cortelloni C; De Vreese L
Clin Ter; 1990 Mar; 132(6 Suppl):457-68. PubMed ID: 2140970
[TBL] [Abstract][Full Text] [Related]
13. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
14. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain.
Bonavita E
Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):511-6. PubMed ID: 3781687
[TBL] [Abstract][Full Text] [Related]
15. Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholism.
Tempesta E; Troncon R; Janiri L; Colusso L; Riscica P; Saraceni G; Gesmundo E; Calvani M; Benedetti N; Pola P
Int J Clin Pharmacol Res; 1990; 10(1-2):101-7. PubMed ID: 2201652
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
Daléry J; Aubin V
Encephale; 2001; 27(1):71-81. PubMed ID: 11294041
[TBL] [Abstract][Full Text] [Related]
17. [A follow-up study on a randomized, single-blind control of King's Brain pills in treatment of memory disorder in elderly people with MCI in a Beijing community].
Tian JZ; Zhu AH; Zhong J
Zhongguo Zhong Yao Za Zhi; 2003 Oct; 28(10):987-91. PubMed ID: 15620194
[TBL] [Abstract][Full Text] [Related]
18. Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.
Filip V; Kolibás E
J Psychiatry Neurosci; 1999 May; 24(3):234-43. PubMed ID: 10354658
[TBL] [Abstract][Full Text] [Related]
19. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic.
Brodaty H; Moore CM
Int J Geriatr Psychiatry; 1997 Jun; 12(6):619-27. PubMed ID: 9215942
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychological changes in demented patients treated with acetyl-L-carnitine.
Sinforiani E; Iannuccelli M; Mauri M; Costa A; Merlo P; Bono G; Nappi G
Int J Clin Pharmacol Res; 1990; 10(1-2):69-74. PubMed ID: 2387665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
